EBITDA DeclineLower adjusted EBITDA is expected due to a decrease in the higher-margin health vertical.
Health Segment ChallengesWhile the company expects the implementation of these procedures, coupled with previous actions, to reduce 2025 under-65 Transaction Value by approximately $80–85M and under-65 Contribution by $18–20M, it remains committed to the Health vertical more broadly.
Regulatory ComplianceManagement announced a settlement with the FTC that will result in a $45 million penalty and additional compliance costs.